Dr. Taine Pechet

About Dr. Taine Pechet

Dr. Taine Pechet is a thoracic oncologist at Penn Medicine in Philadelphia. He serves as chief of surgery at Penn Presbyterian Medical Center and professor of clinical surgery. His clinical practice includes pleural mesothelioma and advanced lung cancer.

He earned his medical degree from Harvard Medical School and completed his surgical residency and chief residency at Brigham and Women’s Hospital before completing a thoracic surgery fellowship at Barnes-Jewish Hospital and Washington University School of Medicine. He is board-certified in both surgery and thoracic surgery and also serves as a staff physician at the Philadelphia VA Medical Center and Pennsylvania Hospital.

Medical Education & Experience

• Penn Presbyterian Medical Center (Chief of Surgery)
• Penn Medicine (Professor of Clinical Surgery)
• Philadelphia VA Medical Center (Staff Physician)
• Pennsylvania Hospital (Staff Physician)
• Barnes-Jewish Hospital, Washington University School of Medicine (Fellowship, Thoracic Surgery)
• Brigham & Women’s Hospital, Harvard Medical School (Residency and Chief Residency, Surgery)
• Harvard Medical School (M.D.)
• Harvard University (A.B., Biology)

Awards and Certifications

• American Board of Thoracic Surgery (Diplomate), 2002
• American Board of Surgery (Diplomate), 2000
• Member, Penn Esophageal and Foregut Surgery Services
• Member, Penn Gastrointestinal Cancer Program
• Member, Penn Lung Cancer Program
• Member, Penn Lung Nodule Program
• Member, Penn Thoracic Surgery Program.
• National Board of Medical Examiners (Diplomate), 1993

Why Choose Dr. Taine Pechet for Pleural Mesothelioma

Dr. Pechet has extensive experience in thoracic surgery, including minimally invasive and robotic procedures for lung and pleural cancers. His work at Penn Medicine includes high-definition video technology that gives surgeons a detailed view of structures inside the chest.

“The HD technology provides a much better, clearer, sharper picture that allows us to see incredible details,” Dr. Pechet said. “Some of our procedures require an ability to see tissue only as thick as a few layers of cells, and this system allows us to see the smallest structures.”

He also participates in research involving photodynamic therapy for primary pleural cancers, including mesothelioma. His broader research in thoracic oncology includes recent studies of lung cancer treatment and molecular testing, including work on neoadjuvant chemoimmunotherapy for non-small cell lung cancer.

Publications of Dr. Taine Pechet

• Pechet, T. et al. (2026, July 15). EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non–Small Cell Lung Cancer. Retrieved from https://ascopubs.org/doi/10.1200/PO-25-01207
• Pechet, T. et al. (2026, May). Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy. Retrieved from https://www.ovid.com/jnls/amjclinicaloncology/abstract/10.1097/coc.0000000000001260~real-world-radiographic-response-rates-and-preoperative?redirectionsource=fulltextview
• Pechet, T. et al. (2017, July). First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non–Small-Cell Lung Cancer. Retrieved from https://www.clinical-lung-cancer.com/article/S1525-7304(16)30385-0/abstract
• Pechet, T. et al. (2013, May 29). Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer. Retrieved from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.28131
• Pechet, T. et al. (2007, December). Management of an Anterior Mediastinal Pheochromocytoma Causing Tracheomalacia. Retrieved from https://www.annalsthoracicsurgery.org/article/S0003-4975(07)01342-2/fulltext